Literature DB >> 27289182

Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells.

Angélica Horrillo1, Gracia Porras1, Matilde S Ayuso1, Consuelo González-Manchón2.   

Abstract

Podocalyxin (Podxl) has an essential role in the development and function of the kidney glomerular filtration barrier. It is also expressed by vascular endothelia but perinatal lethality of podxl(-/-) mice has precluded understanding of its function in adult vascular endothelial cells (ECs). In this work, we show that conditional knockout mice with deletion of Podxl restricted to the vascular endothelium grow normally but most die spontaneously around three months of age. Histological analysis showed a nonspecific inflammatory infiltrate within the vessel wall frequently associated with degenerative changes, and involving vessels of different caliber in one or more organs. Podxl-deficient lung EC cultures exhibit increased permeability to dextran and macrophage transmigration. After thrombin stimulation, ECs lacking Podxl showed delayed recovery of VE-cadherin cell contacts, persistence of F-actin stress fibers, and sustained phosphorylation of the ERM complex and activation of RhoA, suggesting a failure in endothelial barrier stabilization. The results suggest that Podxl has an essential role in the regulation of endothelial permeability by influencing the mechanisms involved in the restoration of endothelial barrier integrity after injury.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Endothelial cell; Inflammation; Podocalyxin; Vascular permeability

Mesh:

Substances:

Year:  2016        PMID: 27289182     DOI: 10.1016/j.ejcb.2016.04.006

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  15 in total

1.  A Single-Cell Transcriptome Atlas of the Mouse Glomerulus.

Authors:  Nikos Karaiskos; Mahdieh Rahmatollahi; Anastasiya Boltengagen; Haiyue Liu; Martin Hoehne; Markus Rinschen; Bernhard Schermer; Thomas Benzing; Nikolaus Rajewsky; Christine Kocks; Martin Kann; Roman-Ulrich Müller
Journal:  J Am Soc Nephrol       Date:  2018-05-24       Impact factor: 10.121

2.  Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development.

Authors:  Yong Kyun Kim; Ido Refaeli; Craig R Brooks; Peifeng Jing; Ramila E Gulieva; Michael R Hughes; Nelly M Cruz; Yannan Liu; Angela J Churchill; Yuliang Wang; Hongxia Fu; Jeffrey W Pippin; Lih Y Lin; Stuart J Shankland; A Wayne Vogl; Kelly M McNagny; Benjamin S Freedman
Journal:  Stem Cells       Date:  2017-09-29       Impact factor: 6.277

3.  Atypical focal segmental glomerulosclerosis associated with a new PODXL nonsense variant.

Authors:  David Marx; Sophie Caillard; Jérôme Olagne; Bruno Moulin; Thierry Hannedouche; Guy Touchard; Arnaud Dupuis; Christian Gachet; Anne Molitor; Seiamak Bahram; Raphael Carapito
Journal:  Mol Genet Genomic Med       Date:  2021-03-29       Impact factor: 2.183

4.  Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis.

Authors:  Madhav Mantri; Gaetano J Scuderi; Roozbeh Abedini-Nassab; Michael F Z Wang; David McKellar; Hao Shi; Benjamin Grodner; Jonathan T Butcher; Iwijn De Vlaminck
Journal:  Nat Commun       Date:  2021-03-19       Impact factor: 14.919

5.  Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis.

Authors:  Mayumi Shoji; Minoru Takemoto; Kazuki Kobayashi; Toshihiro Shoji; Satoka Mori; Jun-Ichi Sagara; Hiroyuki Kurosawa; Yoshiaki Hirayama; Kenichi Sakamoto; Takahiro Ishikawa; Masaya Koshizaka; Yoshiro Maezawa; Koutaro Yokote
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

6.  Promotion of Vascular Morphogenesis of Endothelial Cells Co-Cultured with Human Adipose-Derived Mesenchymal Stem Cells Using Polycaprolactone/Gelatin Nanofibrous Scaffolds.

Authors:  Yun-Min Kook; Hyerim Kim; Sujin Kim; Chan Yeong Heo; Min Hee Park; Kangwon Lee; Won-Gun Koh
Journal:  Nanomaterials (Basel)       Date:  2018-02-18       Impact factor: 5.076

7.  PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets.

Authors:  Siying He; Wenjie Du; Menglan Li; Ming Yan; Fang Zheng
Journal:  BMC Cancer       Date:  2020-07-02       Impact factor: 4.430

8.  Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome.

Authors:  Hee Gyung Kang; Moses Lee; Kyoung Boon Lee; Michael Hughes; Bo Sang Kwon; Sangmoon Lee; Kelly M McNagny; Yo Han Ahn; Jung Min Ko; Il-Soo Ha; Murim Choi; Hae Il Cheong
Journal:  Exp Mol Med       Date:  2017-12-15       Impact factor: 8.718

9.  Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.

Authors:  David Borg; Anna H Larsson; Charlotta Hedner; Björn Nodin; Anders Johnsson; Karin Jirström
Journal:  J Transl Med       Date:  2018-10-24       Impact factor: 5.531

10.  PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.

Authors:  Diana Canals Hernaez; Michael R Hughes; Pamela Dean; Peter Bergqvist; Ismael Samudio; Ola Blixt; Katharina Wiedemeyer; Yicong Li; Chris Bond; Eric Cruz; Martin Köbel; Blake Gilks; Calvin D Roskelley; Kelly M McNagny
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.